Skip to content
Ina HF Carmet
Indonesian Heart Failure and Cardiometabolic Disease Working Group
Ina HF CarmetIna HF Carmet
  • Home
  • About
    • About InaHF
    • Committee
    • Members
  • News
  • Events
    • Event
    • Past Event
  • Recording
  • HF Clinic
  • LIB & Guidelines
    • InaHF Position Statements
    • InaHF National Guidelines
    • International Guidelines
    • Member Publication
  • i-HEFCARD
    • i-HEFCARD 2024
      • i-HEFCARD 2024 Day 1
      • i-HEFCARD 2024 Day 2
    • i-HEFCARD 2023
      • i-HEFCARD 2023 Day 1
      • i-HEFCARD 2023 Day 2
i-TREAT HFHF Unfolded Podcast
Close
  • Home
  • About
    • About InaHF
    • Committee
    • Members
  • News
  • Events
    • Event
    • Past Event
  • Recording
  • HF Clinic
  • LIB & Guidelines
    • InaHF Position Statements
    • InaHF National Guidelines
    • International Guidelines
    • Member Publication
  • i-HEFCARD
    • i-HEFCARD 2024
      • i-HEFCARD 2024 Day 1
      • i-HEFCARD 2024 Day 2
    • i-HEFCARD 2023
      • i-HEFCARD 2023 Day 1
      • i-HEFCARD 2023 Day 2

Defining cardiotoxicity of cancer therapies

You are here:
  1. Home
  2. Library
  3. Defining cardiotoxicity of cancer therapies
Defining-cardiotoxicity-of-cancer-therapies-Anna-Mira-Lubis

Defining cardiotoxicity of cancer therapies – Anna Mira Lubis

Download

National Cardiovascular Center Harapan Kita
Division of Clinical Cardiology, Ward No 2, Level 4
Letjen S. Parman Street No.Kav.87,
RT.1/RW.8, North Bambu City
Palmerah, West Jakarta City, Jakarta 11420.
Follow Us

Find us on:

Twitter page opens in new windowYouTube page opens in new windowInstagram page opens in new windowMail page opens in new window

© 2025 INA HF CARMET. All Rights Reserved

Developed & Managed by ahaa media

Go to Top